Trial Outcomes & Findings for Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation (NCT NCT02911805)
NCT ID: NCT02911805
Last Updated: 2025-12-05
Results Overview
Early Treatment Diabetic Retinopathy Study (ETDRS) chart was used. Higher scores mean a better outcome. The number of correct responses (e.g., number of letters read correctly) from a subject assessed prior to start of the first session of the the 12 week study was subtracted from the number of correct responses elicited at the end of the last session of the study. The means of these differences for each study group (Balance Training vs Aerobic Exercise) were compared by two-tailed t-test.
ACTIVE_NOT_RECRUITING
NA
14 participants
12 weeks
2025-12-05
Participant Flow
Participant milestones
| Measure |
Aerobic Exercise
Exercise 3 times a week
Aerobic exercise: Stationary bicycle ergometer @ 50-80% of maximal heart rate reserve for 20 minutes to 45 minutes
|
Balance Training
Group balance training 3 times a week
Balance exercise: Instructor-led exercises done in a group setting for strengthening, balance, flexibility
|
|---|---|---|
|
Overall Study
STARTED
|
6
|
8
|
|
Overall Study
COMPLETED
|
6
|
8
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Bridging Animal and Human Models of Exercise-induced Visual Rehabilitation
Baseline characteristics by cohort
| Measure |
Aerobic Exercise
n=6 Participants
Exercise 3 times a week
Aerobic exercise: Stationary bicycle ergometer @ 50-80% of maximal heart rate reserve for 20 minutes to 45 minutes
|
Balance Training
n=8 Participants
Group balance training 3 times a week
Balance exercise: Instructor-led exercises done in a group setting for strengthening, balance, flexibility
|
Total
n=14 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=37 Participants
|
0 Participants
n=37 Participants
|
0 Participants
n=74 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=37 Participants
|
0 Participants
n=37 Participants
|
0 Participants
n=74 Participants
|
|
Age, Categorical
>=65 years
|
6 Participants
n=37 Participants
|
8 Participants
n=37 Participants
|
14 Participants
n=74 Participants
|
|
Age, Continuous
|
73.7 years
STANDARD_DEVIATION 8.6 • n=37 Participants
|
73.1 years
STANDARD_DEVIATION 4.0 • n=37 Participants
|
73.4 years
STANDARD_DEVIATION 6.1 • n=74 Participants
|
|
Sex: Female, Male
Female
|
6 Participants
n=37 Participants
|
7 Participants
n=37 Participants
|
13 Participants
n=74 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=37 Participants
|
1 Participants
n=37 Participants
|
1 Participants
n=74 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=37 Participants
|
0 Participants
n=37 Participants
|
0 Participants
n=74 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=37 Participants
|
0 Participants
n=37 Participants
|
0 Participants
n=74 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=37 Participants
|
0 Participants
n=37 Participants
|
0 Participants
n=74 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=37 Participants
|
3 Participants
n=37 Participants
|
6 Participants
n=74 Participants
|
|
Race (NIH/OMB)
White
|
2 Participants
n=37 Participants
|
2 Participants
n=37 Participants
|
4 Participants
n=74 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=37 Participants
|
0 Participants
n=37 Participants
|
0 Participants
n=74 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=37 Participants
|
3 Participants
n=37 Participants
|
4 Participants
n=74 Participants
|
|
Region of Enrollment
United States
|
6 Participants
n=37 Participants
|
8 Participants
n=37 Participants
|
14 Participants
n=74 Participants
|
PRIMARY outcome
Timeframe: 12 weeksPopulation: As per baseline analysis population description.
Early Treatment Diabetic Retinopathy Study (ETDRS) chart was used. Higher scores mean a better outcome. The number of correct responses (e.g., number of letters read correctly) from a subject assessed prior to start of the first session of the the 12 week study was subtracted from the number of correct responses elicited at the end of the last session of the study. The means of these differences for each study group (Balance Training vs Aerobic Exercise) were compared by two-tailed t-test.
Outcome measures
| Measure |
Aerobic Exercise
n=6 Participants
Exercise 3 times a week
Aerobic exercise: Stationary bicycle ergometer @ 50-80% of maximal heart rate reserve for 20 minutes to 45 minutes
|
Balance Training
n=8 Participants
Group balance training 3 times a week
Balance exercise: Instructor-led exercises done in a group setting for strengthening, balance, flexibility
|
|---|---|---|
|
Visual Acuity - Mean Acuity Change
|
7.333 Letters read correctly
Standard Deviation 8.501
|
-4.875 Letters read correctly
Standard Deviation 10.58
|
SECONDARY outcome
Timeframe: 12 weeksContrast sensitivity: The contrast sensitivity of the subjects will be measured with the Pelli-Robson Chart or Contrast Sensitivity Chart following the instructions provided with the chart. The two sides of the Pelli-Robson Chart have different letter sequences but are otherwise identical. The chart should be illuminated as uniformly as possible, so that the luminance of the white areas is between 80 and 120 cd/ m2 with no glare. The patient should sit directly in front of the chart at a distance of 1 meter (use the same 1 meter string as for visual acuity testing to measure the eye-to-chart distance). Subjects should be prevented from seeing the chart until the contrast sensitivity testing actually begins. Subjects should wear their best distance correction.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: 12 weeksBlood will be drawn prior to and after exercise sessions. From this, serum levels of brain derived neurotrophic factor (BDNF) will measured by immunoenzymatic assay.
Outcome measures
Outcome data not reported
Adverse Events
Aerobic Exercise
Balance Training
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place